Four CSE-listed cannabis companies could face sanctions from a provincial securities regulatory body as part of an “abusive” market scheme.

On Monday (November 26), the British Columbia Securities Commission (BCSC) issued a notice blocking a group of consultants denominated as the BridgeMark Group from buying or selling shares of 11 companies trading on the Canadian Securities Exchange (CSE).


Peter Brady, executive director of the BCSC, is alleging participation in a scheme described as “abusive to the capital markets” in which the consultants purchased shares of the companies under a special setting that they didn’t deserve.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“The executive director alleges that the securities sales to BridgeMark were illegal because they improperly used the consultant exemption to avoid filing a prospectus, a formal document that provides details of an investment,” the BCSC said.

Brady argues, “the BridgeMark Group’s members are not consultants, that they provided little or no consulting services to the issuing companies, and engaged in the scheme for their own profit.”

The BCSC has now blocked all current CSE issuers from selling shares using the consultant exemption without a prospectus to the BridgeMark Group.

“Staff are concerned that members of the BridgeMark Group generated profits for themselves and that the Issuers raised capital through the scheme,” the BCSC says in its full notice of hearing.

Here is a list of the 11 companies included in the BCSC announcement:

The BCSC shows that transactions between the group of issuers and the BridgeMark Group took place between February and August:

Data from British Columbia Securities Commission notice of hearing.

A hearing on an extension of the temporary bans by the BCSC is scheduled for December 7.

“If there are findings that those allegations are true, then there would be sanctions from our administrative tribunal,” Brian Kladko, spokesperson for the BCSC, told the Investing News Network.

The allegations remain unproven, and the BCSC will continue its investigation into these companies.

From the 11 companies, the BCSC argues Cryptobloc Technologies, New Point Exploration, Green 2 Blue Energy and BLOK Technologies paid approximately C$15.3 million back to the BridgeMark Group following the raise from the BridgeMark Group.

“The four companies subsequently issued news releases saying they had raised a certain amount of money by selling their shares, even though they had paid most of the purchase amount back to BridgeMark,” the BCSC says.

Effectively, the BCSC alleges, under the guise of private placements, the BridgeMark Group obtained actual free-trading securities of these companies with the consultant exemption and compensation from the companies.

The BridgeMark Group then went on to sell the shares gained from these companies for net profits of C$6.2 million.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

BCSC contends the actual status of members associated with the BridgeMark Group as actual consultants, which granted them the “Consultant Exemption.”

According to the BCSC, the total number of shares purchased by the BridgeMark Group through the private placements was 252,147,883.

The provincial securities regulatory agency is “concerned” members of the BridgeMark Group used the same tactic with the rest of the companies listed.

SpeakEasy issued an update to investors saying it has “undergone several changes over the past number of months, including significant changes to its management team.”

Anthony K. Jackson, one of the respondents cited in the BCSC announcement, was a director and CFO for SpeakEasy up until September.

Similarly, on Wednesday (November 28), Liht Cannabis issued a statement to shareholders confirming its engagement in consulting services from members of the BridgeMark Group.

“Prior to the announcement, the Company had undertaken its own internal investigation and fact-finding, to reconcile the contracts and services rendered to the Company,” Liht Cannabis said.

The company, formerly known as Marapharm Ventures, said its internal investigation has not finished.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: BLOK Technologies, New Point Exploration and PreveCeutical Medical are clients of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less